Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
132.69
-0.19 (-0.14%)
At close: Jun 24, 2026, 4:00 PM EDT
132.60
-0.09 (-0.07%)
After-hours: Jun 24, 2026, 7:33 PM EDT
Apogee Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Downgrades $133 → $135 | Hold | Downgrades | $133 → $135 | +1.74% | Jun 24, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $110 → $135 | Hold | Downgrades | $110 → $135 | +1.74% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades $133 | Hold | Downgrades | $133 | -0.11% | Jun 23, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades $160 → $135 | Hold | Downgrades | $160 → $135 | +1.74% | Jun 23, 2026 |
| Citi | Citi | Hold Downgrades $125 → $135 | Hold | Downgrades | $125 → $135 | +1.74% | Jun 23, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades $97 → $135 | Hold | Downgrades | $97 → $135 | +1.74% | Jun 23, 2026 |
| UBS | UBS | Hold Downgrades $100 → $135 | Hold | Downgrades | $100 → $135 | +1.82% | Jun 23, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Downgrades $116 → $135 | Hold | Downgrades | $116 → $135 | +1.74% | Jun 22, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.